Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Skin Cancer01:30

Skin Cancer

6.6K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
6.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Streamlining the Abstract Selection Process for the American Society of Breast Surgeons' Annual Meeting by Utilizing Large Language Models.

Annals of surgical oncology·2026
Same author

Expanding Eligibility for Targeted Axillary Dissection.

Annals of surgical oncology·2026
Same author

ASO Visual Abstract: Accuracy of Index Lymph Node Pathology in Predicting Overall Response to Neoadjuvant Immunotherapy for Clinical Stage III Melanoma-Results from the Prospective NeoACTIVATE Arm C (NCT03554083) Substudy.

Annals of surgical oncology·2026
Same author

ASO Author Reflections: When Is the Index Lymph Node Not Enough?

Annals of surgical oncology·2026
Same author

Accuracy of Index Lymph Node Pathology in Predicting Overall Response to Neoadjuvant Immunotherapy for Clinical Stage III Melanoma: Results From the Prospective NeoACTIVATE Arm C (NCT03554083) Substudy.

Annals of surgical oncology·2026
Same author

Surgical nodal sampling established by Commission on Cancer Standard 5.8 is essential for accurate lung cancer staging.

JTCVS open·2026
Same journal

Innovative management of Anterior Cutaneous Nerve Entrapment Syndrome (ACNES): A meta-analysis and introduction of a new robotic approach with patient-based algorithm.

American journal of surgery·2026
Same journal

Does the risk outweigh the benefit? Clot progression, recanalization & complications of anticoagulation therapy in acute pancreatitis with concomitant splanchnic vein thrombosis.

American journal of surgery·2026
Same journal

High and low body mass index and 90-day postoperative outcomes in patients with Crohn's disease undergoing abdominal surgery.

American journal of surgery·2026
Same journal

Women with firearm injuries: A multicenter mixed-methods study.

American journal of surgery·2026
Same journal

SBAS presidential address: A surgeon-scientist's journey from haptic science to digital performance metrics.

American journal of surgery·2026
Same journal

Using Dr. Google and AI to stay informed.

American journal of surgery·2026
See all related articles

Related Experiment Video

Updated: Apr 5, 2026

A 3D Organotypic Melanoma Spheroid Skin Model
08:49

A 3D Organotypic Melanoma Spheroid Skin Model

Published on: May 18, 2018

16.8K

Multiple primary melanoma in the elderly.

Adam C Krajewski1, Donna R Hart2, Tina J Hieken3

  • 1Department of Surgery, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA.

American Journal of Surgery
|August 26, 2015
PubMed
Summary
This summary is machine-generated.

Elderly patients diagnosed with melanoma have a significant risk of developing multiple primary melanomas (MPM). Prior dysplastic nevi are a key risk factor, necessitating vigilant surveillance in older adults.

Keywords:
Dysplastic neviElderlyMelanomaMultiple primary melanoma

More Related Videos

Implantation and Evaluation of Melanoma in the Murine Choroid via Optical Coherence Tomography
05:46

Implantation and Evaluation of Melanoma in the Murine Choroid via Optical Coherence Tomography

Published on: December 2, 2022

2.3K
Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells
06:09

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells

Published on: June 7, 2019

9.7K

Related Experiment Videos

Last Updated: Apr 5, 2026

A 3D Organotypic Melanoma Spheroid Skin Model
08:49

A 3D Organotypic Melanoma Spheroid Skin Model

Published on: May 18, 2018

16.8K
Implantation and Evaluation of Melanoma in the Murine Choroid via Optical Coherence Tomography
05:46

Implantation and Evaluation of Melanoma in the Murine Choroid via Optical Coherence Tomography

Published on: December 2, 2022

2.3K
Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells
06:09

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells

Published on: June 7, 2019

9.7K

Area of Science:

  • Dermatology
  • Oncology
  • Geriatrics

Background:

  • Limited data exist on multiple primary melanoma (MPM) surveillance in elderly populations.
  • Investigating whether incidence and risk factors for MPM differ in older versus younger patients.

Purpose of the Study:

  • To determine the frequency and characteristics of MPM in patients aged 65 and older.
  • To identify risk factors associated with MPM in the elderly melanoma population.

Main Methods:

  • Prospective melanoma registry analysis of 222 consecutive patients aged 65+ at initial diagnosis.
  • Mean follow-up duration of 65 ± 3 months.

Main Results:

  • 10% of elderly patients developed a second primary melanoma; 4% developed three or more.
  • Second primary melanomas were often similar or thinner than the initial melanoma.
  • Third primary melanomas were more frequently thicker; prior dysplastic nevi were a significant risk factor (P <.0001).

Conclusions:

  • Elderly melanoma patients face a substantial risk of MPM, underscoring the need for careful surveillance.
  • Prompt detection and treatment are crucial for managing MPM in older adults.
  • Patients with a history of dysplastic nevi require heightened scrutiny for MPM.